Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma
Zweegman, Sonja, van der Holt, Bronno, Mellqvist, Ulf-Henrik, Salomo, Morten, Bos, Gerard M.J., Levin, Mark-David, Visser-Wisselaar, Heleen, Hansson, Markus, van der Velden, Annette W.G., Deenik, Wendy, Gruber, Astrid, Coenen, Juleon L.L.M., Plesner, Torben, Klein, Saskia K., Tanis, Bea C., Szatkowski, Damian L., Brouwer, Rolf E., Westerman, Matthijs, Leys, M.(Rineke) B.L., Sinnige, Harm A.M., Haukås, Einar, van der Hem, Klaas G., Durian, Marc F., Mattijssen, E.(Vera)J.M., van de Donk, Niels W.C.J., Stevens-Kroef, Marian J.P.L., Sonneveld, Pieter, Waage, Anders
Published in Blood (03.03.2016)
Published in Blood (03.03.2016)
Get full text
Journal Article
Ixazomib-Thalidomide-low dose dexamethasone induction followed by maintenance therapy with ixazomib or placebo in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplantation; results from the randomized phase II HOVON-126/NMSG 21.13 trial
Zweegman, Sonja, Stege, Claudia A M, Haukas, Einar, Schjesvold, Fredrik H, Levin, Mark-David, Waage, Anders, Leys, Rineke B L, Klein, Saskia K, Szatkowski, Damian, Axelsson, Per, Hieu Do, Trung, Knut-Bojanowska, Dorota, van der Spek, Ellen, Svirskaite, Asta, Klostergaard, Anja, Salomo, Morten, Blimark, Celine, Ypma, Paula F, Mellqvist, Ulf-Henrik, Poddighe, Pino J, Stevens-Kroef, Marian, van de Donk, Niels W C J, Sonneveld, Pieter, Hansson, Markus, van der Holt, Bronno, Abildgaard, Niels
Published in Haematologica (Roma) (01.12.2020)
Published in Haematologica (Roma) (01.12.2020)
Get full text
Journal Article
Health-related quality of life in transplant ineligible newly diagnosed multiple myeloma patients treated with either thalidomide or lenalidomide-based regimen until progression: a prospective, open-label, multicenter, randomized, phase 3 study
Nielsen, Lene Kongsgaard, Stege, Claudia, Lissenberg-Witte, Birgit, van der Holt, Bronno, Mellqvist, Ulf-Henrik, Salomo, Morten, Bos, Gerard, Levin, Mark-David, Visser-Wisselaar, Heleen, Hansson, Markus, van der Velden, Annette, Deenik, Wendy, Coenen, Juleon, Hinge, Maja, Klein, Saskia, Tanis, Bea, Szatkowski, Damian, Brouwer, Rolf, Westerman, Matthijs, Leys, Rineke, Sinnige, Harm, Haukås, Einar, van der Hem, Klaas, Durian, Marc, Gimsing, Peter, van de Donk, Niels, Sonneveld, Pieter, Waage, Anders, Abildgaard, Niels, Zweegman, Sonja
Published in Haematologica (Roma) (01.06.2020)
Published in Haematologica (Roma) (01.06.2020)
Get full text
Journal Article
P898: A PROSPECTIVE PHASE 2 STUDY TO ASSESS MINIMAL RESIDUAL DISEASE AFTER IXAZOMIB, LENALIDOMIDE, DEXAMETHASONE (IRD) TREATMENT FOR NEWLY DIAGNOSED TRANSPLANT ELIGIBLE MULTIPLE MYELOMA PATIENTS
Silvennoinen, Raija, Partanen, Anu, Waage, Anders, Pečeliūnas, Valdas, Schjesvold, Fredrik, Anttila, Pekka, Uttervall, Katarina, Säily, Marjaana, Putkonen, Mervi, Carlson, Kristina, Haukas, Einar, Sankelo, Marja, Szatkowski, Damian, Hansson, Markus, Marttila, Anu, Axelsson, Per, Svensson, Ronald, Lauri, Birgitta, Mikkola, Maija, Karlsson, Conny, Abelsson, Johanna, Ahlstrand, Erik, Sikiö, Anu, Klimkowska, Monika, Matuzeviciene, Reda, Hoyseter Fenstad, Mona, Ilveskero, Sorella, Nahi, Hareth
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
Ixazomib‐Thalidomide‐Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long‐term Results of HOVON‐126/NMSG 21.13
Groen, Kazimierz, Schjesvold, Fredrik H., Holt, Bronno, Levin, Mark‐David, Seefat, Maarten R., Hansson, Markus, Leys, Maria B.L., Regelink, Josien C., Waage, Anders, Szatkowski, Damian, Axelsson, Per, Hieu Do, Trung, Svirskaite, Asta, Spek, Ellen, Haukas, Einar, Knut‐Bojanowska, Dorota, Ypma, Paula F., Blimark, Cecilie H., Mellqvist, Ulf‐Henrik, Donk, Niels W.C.J., Sonneveld, Pieter, Klostergaard, Anja, Vangsted, Annette J., Abildgaard, Niels, Zweegman, Sonja
Published in HemaSphere (01.09.2023)
Published in HemaSphere (01.09.2023)
Get full text
Journal Article
Ixazomib-Thalidomide-low dose dexamethasone induction followed by maintenance therapy with ixazomib or placebo in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplantation; results from the randomized phase II HOVON-126/NMSG 21.13 trial
Zweegman, Sonja, Stege, Claudia A M, Haukas, Einar, Schjesvold, Fredrik H, Levin, Mark-David, Waage, Anders, Leys, Rineke B L, Klein, Saskia K, Szatkowski, Damian, Axelsson, Per, Hieu Do, Trung, Knut-Bojanowska, Dorota, van der Spek, Ellen, Svirskaite, Asta, Klostergaard, Anja, Salomo, Morten, Blimark, Celine, Ypma, Paula F, Mellqvist, Ulf-Henrik, Poddighe, Pino J, Stevens-Kroef, Marian, van de Donk, Niels W C J, Sonneveld, Pieter, Hansson, Markus, van der Holt, Bronno, Abildgaard, Niels
Published in Haematologica (Roma) (01.12.2020)
Published in Haematologica (Roma) (01.12.2020)
Get full text
Journal Article
P-222: A prospective phase 2 study to assess minimal residual disease after ixazomib plus lenalidomide plus dexamethasone (IRd) treatment for newly diagnosed transplant eligible multiple myeloma patients
Silvennoinen, Raija, Waage, Anders, Peceliunas, Valdas, Schjesvold, Fredrik, Anttila, Pekka, Uttervall, Katarina, Säily, Marjaana, Putkonen, Mervi, Carlson, Kristina, Haukas, Einar, Sankelo, Marja, Partanen, Anu, Szatkowski, Damian, Hansson, Markus, Marttila, Anu, Svensson, Ronald, Axelsson, Per, Lauri, Birgitta, Mikkola, Maija, Karlsson, Conny, Abelsson, Johanna, Ahlstrand, Erik, Sikiö, Anu, Nahi, Hareth
Published in Clinical lymphoma, myeloma and leukemia (01.08.2022)
Published in Clinical lymphoma, myeloma and leukemia (01.08.2022)
Get full text
Journal Article
Ixazomib-Thalidomide-Low Dose Dexamethasone (ITd) Induction Followed By Maintenance Therapy with Ixazomib or Placebo in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem Cell Transplantation; Results from the Randomized Phase II HOVON-126/Nmsg 21#13 Trial
Zweegman, Sonja, Schjesvold, Fredrik H., van der Holt, Bronno, Levin, Mark-David, Stege, Claudia A.M., Waage, Anders, Leijs, Maria B.L., Klein, Saskia K., Szatkowski, Damian L., Axelsson, Per, Hieu Do, Trung, Knut-Bojanovska, Dorota, van der Spek, Ellen, Svirskaite, Asta, Poddighe, Pino, Stevens-Kroef, Marian, Hansson, Markus, van de Donk, Niels WCJ, Haukas, Einar, Sonneveld, Pieter, Abildgaard, Niels
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
A Prospective Phase 2 Study to Assess Minimal Residual Disease after Ixazomib, Lenalidomide and Dexamethasone Treatment for Newly Diagnosed Transplant Eligible Multiple Myeloma Patients
Silvennoinen, Raija Helena, Waage, Anders, Peceliunas, Valdas, Schjesvold, Fredrik, Anttila, Pekka, Säily, Marjaana, Putkonen, Mervi, Carlson, Kristina, Haukaas, Einar, Sankelo, Marja, Partanen, Anu, Szatkowski, Damian L., Hansson, Markus, Marttila, Anu, Ahlberg, Lucia, Axelsson, Per, Lauri, Birgitta, Mikkola, Maija Helena, Karlsson, Conny, Abelsson, Johanna, Ahlstrand, Erik, Sikiö, Anu, Klimkowska, Monika, Matuzeviciene, Reda, Hoysaeter Fenstad, Mona, Ilveskero, Sorella, Nahi, Hareth
Published in BLOOD (05.11.2020)
Published in BLOOD (05.11.2020)
Get full text
Journal Article
Conference Proceeding
Ixazomib, Lenalidomide, and Dexamethasone (IRD) Treatment with Cytogenetic Risk-Based Maintenance in Transplant-Eligible Myeloma: A Phase 2 Multicenter Study by the Nordic Myeloma Study Group
Partanen, Anu, Waage, Anders, Peceliunas, Valdas, Schjesvold, Fredrik, Anttila, Pekka, Säily, Marjaana, Uttervall, Katarina, Putkonen, Mervi, Carlson, Kristina, Haukas, Einar, Sankelo, Marja, Szatkowski, Damian, Hansson, Markus, Marttila, Anu, Svensson, Ronald, Axelsson, Per, Lauri, Birgitta, Mikkola, Maija, Karlsson, Conny, Abelsson, Johanna, Ahlstrand, Erik, Sikiö, Anu, Klimkowska, Monika, Matuzeviciene, Reda, Fenstad, Mona Hoysaeter, Ilveskero, Sorella, Pelliniemi, Tarja-Terttu, Nahi, Hareth, Silvennoinen, Raija
Published in Cancers (29.02.2024)
Published in Cancers (29.02.2024)
Get full text
Journal Article
Ixazomib-Thalidomide-Low Dose Dexamethasone (ITd) Induction Followed By Maintenance Therapy with Ixazomib or Placebo in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem Cell Transplantation; Initial Results from the Randomized Phase II HOVON-126/Nmsg 21.13 Trial
Zweegman, Sonja, van der Holt, Bronno, Schjesvold, Fredrik H., Levin, Mark-David, Stege, Claudia A.M., Waage, Anders, Leijs, Maria Berhardina, Klein, Saskia, Szatkowski, Damian L., Broyl, A, Axelsson, Per, Hieu Do, Trung, Knut-Bojanovska, Dorota, van der Spek, Ellen, Svirskaite, Asta, Cunha, Sonia, Hansson, Markus, Sonneveld, Pieter, Haukaas, Einar, Abildgaard, Niels
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Frailty Predicts Survival and Toxicity in Newly Diagnosed Multiple Myeloma Patients Ineligible for Autologous Stem Cell Transplantation; Report of the HOVON-87/Nmsg-18 Study Group
Stege, Claudia A.M., van der Holt, Bronno, Mellqvist, Ulf-Henrik, Levin, Mark-David, Salomo, Morten, Abildgaard, Niels, Bos, Gerard, Visser-Wisselaar, Heleen, Hansson, Markus, van der Velden, Annette, Deenik, Wendy, Gruber, Astrid, Coenen, Jules L.L.M., Plesner, Torben, Klein, Saskia, Tanis, Bea, Szatkowski, Damian L., Brouwer, Rolf, Westerman, Matthijs, Leijs, Maria Berhardina, Sinnige, Harm, Haukaas, Einar, van der Hem, Klaas, Durian, Marc, Mattijssen, Vera, Gimsing, Peter, Van De Donk, Niels WCJ, Stevens-Kroef, Marian, Sonneveld, Pieter, Waage, Anders, Zweegman, Sonja
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Randomized Phase III Trial in Non-Transplant Eligible Patients with Newly Diagnosed Symptomatic Multiple Myeloma Comparing Melphalan-Prednisone-Thalidomide Followed By Thalidomide Maintenance (MPT-T) Versus Melphalan-Prednisone-Lenalidomide Followed By Maintenance with Lenalidomide (MPR-R); A Joint Study of the Dutch-Belgian Cooperative Trial Group for Hematology Oncology (HOVON) and the Nordic Myeloma Study Group (NMSG)
Zweegman, Sonja, Holt, Bronno van der, Mellqvist, Ulf-Henrik, Salomo, Morten, Bos, Gerard M.J., Levin, Mark-David, Visser-Wisselaar, Heleen A, Hansson, Markus, van der Velden, Annette WG, Deenik, Wendy, Gruber, Astrid, Coenen, Juleon LLM, Plesner, Torben, Klein, Saskia K, Tanis, Bea, Szatkowski, Damian L, Brouwer, Rolf, Westerman, Matthijs, Leys, M (Rineke) BL, van de Donk, Niels W.C.J., Haukås, Einar, van der Hem, Klaas, Durian, MF, Mattijssen, E (Vera) JM, Sinnige, Harm AM, Stevens-Kroef, Marian JPL, Sonneveld, Pieter, Waage, Anders
Published in BLOOD (06.12.2014)
Published in BLOOD (06.12.2014)
Get full text
Journal Article
Conference Proceeding
α-Melanocyte-Stimulating Hormone Modulates Nitric Oxide Production in Melanocytes
TSATMALI, M, GRAHAM, A, SZATKOWSKI, D, ANCANS, J, MANNING, P, MCNEIL, C. J, GRAHAM, A. M, THODY, A. J
Published in Journal of investigative dermatology (01.03.2000)
Published in Journal of investigative dermatology (01.03.2000)
Get full text
Journal Article
Imatinib targeted therapy for a patient with chronic eosinophilic leukemia
Prejzner, Witold, Szatkowski, Damian, Wasag, Bartosz, Limon, Janusz, Hellmann, Andrzej
Published in Contemporary oncology (Poznań, Poland) (01.01.2005)
Get full text
Published in Contemporary oncology (Poznań, Poland) (01.01.2005)
Journal Article
[alpha]-Melanocyte-Stimulating Hormone Modulates Nitric Oxide Production in Melanocytes1
Tsatmali, Marina, Graham, Alison, Szatkowski, Damian, Ancans, Janis, Manning, Philip, McNeil, Calum J, Graham, Anne M, Thody, Anthony J
Published in Journal of investigative dermatology (01.03.2000)
Published in Journal of investigative dermatology (01.03.2000)
Get full text
Journal Article